Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katherine R Kozak

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Bioanalysis|March 23, 2011
Challenges in developing bioanalytical assays for characterization of antibody-drug conjugatesJean Philippe Stephan, Katherine R Kozak, Wai Lee T Wong
Journal of Neuroscience Research|April 25, 2007
Characterization of the rat urokinase plasminogen activator receptor promoter in PC12 cellsFeng Su, Katherine R Kozak, Harvey Herschman, et al.
Proteomics|October 21, 2005
Characterization of serum biomarkers for detection of early stage ovarian cancerKatherine R Kozak, Feng Su, Julian P Whitelegge, et al.
Journal of the American Society for Mass Spectrometry|May 31, 2018
Automated On-tip Affinity Capture Coupled with Mass Spectrometry to Characterize Intact Antibody-Drug Conjugates from BloodKe Sherry Li, Phillip Y Chu, Aimee Fourie-O'Donohue, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 20, 2002
Urokinase plasminogen activator receptor: Prognostic biomarker for endometrial cancerSanaz Memarzadeh, Katherine R Kozak, Lisbeth Chang, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 3, 2003
Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: potential use in diagnosis and prognosisKatherine R Kozak, Malaika W Amneus, Suzanne M Pusey, et al.
Bioconjugate Chemistry|November 15, 2019
Development of a Cysteine-Conjugatable Disulfide FRET Probe: Influence of Charge on Linker Cleavage and Payload Trafficking for an Anti-HER2 Antibody ConjugateSuzie J Scales, Siao Ping Tsai, Neelie Zacharias, et al.
Bioconjugate Chemistry|June 2, 2018
FRET Reagent Reveals the Intracellular Processing of Peptide-Linked Antibody-Drug ConjugatesByoung-Chul Lee, Cecile Chalouni, Sophia Doll, et al.
Bioconjugate Chemistry|December 20, 2018
Development, Optimization, and Structural Characterization of an Efficient Peptide-Based Photoaffinity Cross-Linking Reaction for Generation of Homogeneous Conjugates from Wild-Type AntibodiesNicholas Vance, Neelie Zacharias, Mark Ultsch, et al.
Mabs|May 15, 2018
Prediction of non-linear pharmacokinetics in humans of an antibody-drug conjugate (ADC) when evaluation of higher doses in animals is limited by tolerability: Case study with an anti-CD33 ADCIsabel Figueroa, Doug Leipold, Steve Leong, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Bioanalysis|March 23, 2011
Challenges in developing bioanalytical assays for characterization of antibody-drug conjugatesJean Philippe Stephan, Katherine R Kozak, Wai Lee T Wong
Journal of Neuroscience Research|April 25, 2007
Characterization of the rat urokinase plasminogen activator receptor promoter in PC12 cellsFeng Su, Katherine R Kozak, Harvey Herschman, et al.
Proteomics|October 21, 2005
Characterization of serum biomarkers for detection of early stage ovarian cancerKatherine R Kozak, Feng Su, Julian P Whitelegge, et al.
Journal of the American Society for Mass Spectrometry|May 31, 2018
Automated On-tip Affinity Capture Coupled with Mass Spectrometry to Characterize Intact Antibody-Drug Conjugates from BloodKe Sherry Li, Phillip Y Chu, Aimee Fourie-O'Donohue, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 20, 2002
Urokinase plasminogen activator receptor: Prognostic biomarker for endometrial cancerSanaz Memarzadeh, Katherine R Kozak, Lisbeth Chang, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 3, 2003
Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: potential use in diagnosis and prognosisKatherine R Kozak, Malaika W Amneus, Suzanne M Pusey, et al.
Bioconjugate Chemistry|November 15, 2019
Development of a Cysteine-Conjugatable Disulfide FRET Probe: Influence of Charge on Linker Cleavage and Payload Trafficking for an Anti-HER2 Antibody ConjugateSuzie J Scales, Siao Ping Tsai, Neelie Zacharias, et al.
Bioconjugate Chemistry|June 2, 2018
FRET Reagent Reveals the Intracellular Processing of Peptide-Linked Antibody-Drug ConjugatesByoung-Chul Lee, Cecile Chalouni, Sophia Doll, et al.
Bioconjugate Chemistry|December 20, 2018
Development, Optimization, and Structural Characterization of an Efficient Peptide-Based Photoaffinity Cross-Linking Reaction for Generation of Homogeneous Conjugates from Wild-Type AntibodiesNicholas Vance, Neelie Zacharias, Mark Ultsch, et al.
Mabs|May 15, 2018
Prediction of non-linear pharmacokinetics in humans of an antibody-drug conjugate (ADC) when evaluation of higher doses in animals is limited by tolerability: Case study with an anti-CD33 ADCIsabel Figueroa, Doug Leipold, Steve Leong, et al.
Pageof 6